myocardial ischemia reperfusion injury
Conditions
Interventions
conductive sensitization
MIRI group:morphological sensitization
healthy group:morphological sensitization
algetic sensitization
pyretic sensitization
conducive sensitization
Sponsors
the Affiliated Hospital of Shaanxi University of Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 85 Years
Inclusion criteria
Inclusion criteria: MIRI patients: (1) meeting the diagnostic criteria of non-ST elevation acute coronary syndrome in 2023 ESC Guidelines for the management of acute coronary syndromes. (2) received percutaneous coronary intervention within a week. (3) aged 18 to 85 years. (4) willing to participate in this study, and sign on informed consent. Healthy subjects: (1) received a health examination within a week, and confirmed to be in good health. (2) aged 18 to 85 years, and matching the MIRI patients. (3) willing to participate in this study, and sign on informed consent.
Exclusion criteria
Exclusion criteria: (1) diagnosed as ST-elevation myocardial infarction, with persistent ST-segment elevation or ST-segment elevation equivalents on electrocardiogram. (2) combined with disorders of rhythm, disorders of the heart, muscles, valves, and pericardium, and peripheral vascular disease. (3) suffering from neoplastic disorders, hematopoietic disorders, disorders of hemostasis, infectious diseases, immune-mediated, inflammatory, and rheumatologic disorders. (4) combined with fever. (5) suffering from psychiatric disorders, and unable to cooperate. (6) participating in any other study using an unapproved drug within 3 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| mRNA; | — |
Countries
China
Contacts
Public ContactHaifa Qiao
College of Acupuncture and Tuina, Shaanxi University of Chinese Medicine
Outcome results
None listed